|
|
||||||||
Published online before print August 21, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,1
* Department of Drug Research and Evaluation, Istituto Superiore di Sanità, Rome, Italy; and
Division of Infectious Disease, Department of Medicine, Mount Sinai School of Medicine, New York, New York, USA
1 Correspondence: Mt. Sinai School of Medicine, Box 1090, 1 Gustave L. Levy Place, New York, NY 10029, USA. E-mail: mary.klotman{at}mssm.edu
Following retroviral infection of cells, not only is the proviral DNA integrated into the host genome, but there is also an accumulation of unintegrated extrachromosomal DNA (E-DNA), both linear and circular. Although the integrated DNA is responsible for the production of viral proteins and new viral progeny, the role of E-DNA has remained uncertain. Several reports have shown that E-DNA is transcriptionally active producing both RNA, as well as viral proteins and that circular E-DNA can persist in nondividing cells, raising questions regarding the potential consequences of this reservoir. Furthermore, integrase inhibitors, presently in clinical trials, shifts the balance of proviral DNA to the E-DNA form. This review is focused on recent work in this field with an emphasis on exploring the potential role of E-DNA in both pathogenesis of retroviral infections, especially HIV-1, and as a tool to deliver and express genes.
Key Words: unintegrated DNA HIV-1 integrase inhibitors vaccine gene therapy
This article has been cited by other articles:
![]() |
L. J. Montaner, S. M. Crowe, S. Aquaro, C.-F. Perno, M. Stevenson, and R. G. Collman Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs J. Leukoc. Biol., November 1, 2006; 80(5): 961 - 964. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |